Adenosine Signaling in Mast Cells and Allergic Diseases.

Publication date

2021-06-16T16:11:08Z

2021-06-16T16:11:08Z

2021-05-14

2021-06-16T16:11:08Z

Abstract

Adenosine is a nucleoside involved in the pathogenesis of allergic diseases. Its effects are mediated through its binding to G protein-coupled receptors: A1, A2a, A2b and A3. The receptors differ in the type of G protein they recruit, in the effect on adenylyl cyclase (AC) activity and the downstream signaling pathway triggered. Adenosine can produce both an enhancement and an inhibition of mast cell degranulation, indicating that adenosine effects on these receptors is controversial and remains to be clarified. Depending on the study model, A1, A2b, and A3 receptors have shown anti- or pro-inflammatory activity. However, most studies reported an anti-inflammatory activity of A2a receptor. The precise knowledge of the adenosine mechanism of action may allow to develop more efficient therapies for allergic diseases by using selective agonist and antagonist against specific receptor subtypes.

Document Type

Article


Published version

Language

English

Subjects and keywords

Al·lèrgia; Adenosina; Allergy; Adenosine

Publisher

MDPI

Related items

Reproducció del document publicat a: https://doi.org/10.3390/ijms22105203

International Journal of Molecular Sciences, 2021, vol. 22, num. 10

https://doi.org/10.3390/ijms22105203

Recommended citation

This citation was generated automatically.

Rights

cc-by (c) Garcia Garcia, Lucia et al., 2021

https://creativecommons.org/licenses/by/4.0/